Specialist Series

Specialist Series: Reimbursement

If reimbursement is so important … why do so many companies address it so half-heartedly and so late? Edward E. Berger, Ph.D. Everyone knows how important reimbursement analysis and planning is to the success of innovative medical technology and life science products.  Ask any venture capitalist, private equity investor, strategic marketing analyst, or C-level executive;…

Read More

Bringing the Immunity-to-Change™ process to the scientific community

Community member post by Erica Lawlor and Cheryl Vaughan How can scientists whose careers were formed in an incentive system that cultivates competitive and territorial behaviors be helped to meet the expectations of collaborative research frameworks? A team-based approach that transcends disciplinary boundaries may be a tall order for scientists who “grew up” in a…

Read More

Specialist Series: Your Elevator Pitch: Don’t leave home without it!

Written by Melissa Marshall Have you ever walked away from a conversation about your work with an important individual and thought, “Darn. I wish I would have explained that better or said it this way instead…”? Or maybe you had an unexpected interaction with someone who asked about your work and you just started rambling…

Read More

Specialist Series: Patents

What is a U.S. patent? A patent is a property right. The property right granted is an exclusionary right, i.e., the right to exclude others from making, using, offering for sale, or selling an invention. In the US, generally this exclusionary right lasts for 20 years from the date of the initial filing of an…

Read More

Specialist Series: What is a “Venture Syndicate” ?

By Jay Knowles An investor syndicate generally consists of three of four investors who have the funds to take the company from idea stage through to clinical proof of concept.  Investors may not put all of the investment in upfront (so that they have a little more control over the flow of funds), and they…

Read More

SPECIALIST SERIES: What Is An Investible Hypothesis?

By Jay Knowles Partner, Innovation Many venture capitalists look for an opportunity to invest in a company or a project such that if it reaches a certain inflection point that company will become significantly more valuable, and investors look to understand what it should cost to get to that point. For example, for a therapeutic…

Read More

SPECIALIST SERIES: Taking The Next Steps With Medical Research

You have completed your research project, possibly published the results, and maybe presented the work at a conference.  Now what?  Perhaps you would like to see the technology translated into medical practice and meaningful health outcomes.  But what are the next steps? You may think the next logical steps are to refine the technology and…

Read More

SPECIALIST SERIES: What is Due Diligence?

No matter how interested they appear in a deal, prudent investors always follow a process called “due diligence” before making a financial commitment.  That means conducting research on the proposition to test the assertions of the promoters and seek additional information to the point where they are satisfied that they clearly understand the risks they…

Read More